David Matthew T has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 6515 shares of CorMedix Inc. ($CRMD) on January 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | CorMedix Inc. | $CRMD | David Matthew T | Chief Financial Officer | F | Common Stock | 6515 | $11.19 | 95,270.0000 | 58,872 | 6.40% | 11.07% |
| Jan. 2, 2025 | CorMedix Inc. | $CRMD | David Matthew T | Chief Financial Officer | A | Common Stock | 62500 | $0.00 | 110,434.0000 | 58,872 | 130.39% | 100.00% |
| Jan. 2, 2025 | CorMedix Inc. | $CRMD | David Matthew T | Chief Financial Officer | F | Common Stock | 8648 | $8.22 | 101,786.0000 | 58,872 | 7.83% | 14.69% |
| Jan. 12, 2024 | CorMedix Inc. | $CRMD | David Matthew T | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 53,150.0000 | 50,902,931 | 1587.30% | 0.10% |
| Jan. 12, 2024 | CorMedix Inc. | $CRMD | David Matthew T | Chief Financial Officer | F | Common Stock | 5216 | $3.47 | 47,934.0000 | 50,902,931 | 9.81% | 0.01% |
| Jan. 12, 2024 | CorMedix Inc. | $CRMD | David Matthew T | Chief Financial Officer | A | Stock Option (Right to Buy Common Stock) | 100000 | $0.00 | 100,000.0000 | 50,902,931 | 9999.99% | 0.20% |